Relative and Cumulative Effects of Lipid and Blood Pressure Control in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels Trial | Zendy

Pierre Amarenco | Zendy; Larry B. Goldstein | Zendy; Michael Messig | Zendy; Blair J. O’Neill | Zendy; Alfred Callahan | Zendy; Henrik Sillesen | Zendy; Michael G. Hennerici | Zendy; Justin A. Zivin | Zendy; K.M.A. Welch | Zendy

Open Access

Relative and Cumulative Effects of Lipid and Blood Pressure Control in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels Trial

Author(s) -

Pierre Amarenco,

Larry B. Goldstein,

Michael Messig,

Blair J. O’Neill,

Alfred Callahan,

Henrik Sillesen,

Michael G. Hennerici,

Justin A. Zivin,

K.M.A. Welch

Publication year - 2009

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.108.546135

Subject(s) - medicine , stroke (engine) , blood pressure , atorvastatin , hazard ratio , cholesterol , placebo , cardiology , confidence interval , endocrinology , mechanical engineering , engineering , alternative medicine , pathology

The relative contributions of on-treatment low- and high-density lipoprotein cholesterol (LDL-C, HDL-C), triglycerides, and blood pressure (BP) control on the risk of recurrent stroke or major cardiovascular events in patients with stroke is not well defined.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research